Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
12.92
+0.07 (0.54%)
Jul 3, 2026, 3:04 PM CST
SHE:002675 Market Cap
SHE:002675 has a market cap or net worth of 10.65 billion as of July 2, 2026. Its market cap has decreased by -11.39% in one year.
Market Cap
10.65B
Enterprise Value
11.64B
Revenue
2.68B
Ranking
n/a
PE Ratio
52.17
Stock Price
12.92
Market Cap Chart
Since May 25, 2012, SHE:002675's market cap has increased from 3.09B to 10.65B, an increase of 244.92%. That is a compound annual growth rate of 9.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 10.65B | -5.97% |
| Dec 31, 2025 | 11.33B | 12.44% |
| Dec 31, 2024 | 10.08B | -33.33% |
| Dec 29, 2023 | 15.11B | 10.69% |
| Dec 30, 2022 | 13.66B | 7.87% |
| Dec 31, 2021 | 12.66B | -20.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Shyndec Pharmaceutical | 11.96B |
| Zhejiang Garden Biopharmaceutical | 11.83B |
| Henan Lingrui Pharmaceutical | 11.67B |
| Zhejiang Medicine | 11.65B |
| Guangdong Taienkang Pharmaceutical | 11.16B |
| Hubei Hongyuan Pharmaceutical Technology | 10.67B |
| Frontier Biotechnologies | 10.39B |
| Zhejiang CONBA Pharmaceutical | 10.35B |